Scenarios that move NAMS

NewAmsterdam Pharma Company N.V. - Ordinary Shares

Scenarios that move NAMS: 1 analysis, 0 positive, 1 negative.

1. 2026-09-07 · Amgen shares fall after Novartis' Pelacarsen misses Phase III goal — ▼ · impact -35 · confidence low · horizon weeks

All scenarios · Run a scenario · Pricing